JPS58212781A - 新種バクテリオフア−ジ及びその育種法 - Google Patents
新種バクテリオフア−ジ及びその育種法Info
- Publication number
- JPS58212781A JPS58212781A JP57093062A JP9306282A JPS58212781A JP S58212781 A JPS58212781 A JP S58212781A JP 57093062 A JP57093062 A JP 57093062A JP 9306282 A JP9306282 A JP 9306282A JP S58212781 A JPS58212781 A JP S58212781A
- Authority
- JP
- Japan
- Prior art keywords
- bacteriophage
- endonuclease
- dna
- late promoter
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001515965 unidentified phage Species 0.000 title claims abstract description 128
- 238000000034 method Methods 0.000 title claims description 16
- 238000009395 breeding Methods 0.000 title claims description 13
- 230000001488 breeding effect Effects 0.000 title claims description 11
- 108010042407 Endonucleases Proteins 0.000 claims abstract description 81
- 102000004533 Endonucleases Human genes 0.000 claims abstract description 81
- 239000012634 fragment Substances 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 14
- 230000002068 genetic effect Effects 0.000 claims abstract description 12
- 238000013518 transcription Methods 0.000 claims abstract description 7
- 230000035897 transcription Effects 0.000 claims abstract description 7
- 238000003776 cleavage reaction Methods 0.000 claims description 53
- 230000007017 scission Effects 0.000 claims description 53
- 230000014616 translation Effects 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims 2
- 101710163270 Nuclease Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 62
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 102000012410 DNA Ligases Human genes 0.000 abstract description 3
- 108010061982 DNA Ligases Proteins 0.000 abstract description 3
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 description 51
- 239000012137 tryptone Substances 0.000 description 27
- 239000000243 solution Substances 0.000 description 25
- 239000002609 medium Substances 0.000 description 23
- 229920001817 Agar Polymers 0.000 description 20
- 239000008272 agar Substances 0.000 description 20
- 230000002101 lytic effect Effects 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 239000003550 marker Substances 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 108700025695 Suppressor Genes Proteins 0.000 description 4
- 230000001420 bacteriolytic effect Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 101710132601 Capsid protein Proteins 0.000 description 3
- 101710094648 Coat protein Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 101710125418 Major capsid protein Proteins 0.000 description 3
- 101710141454 Nucleoprotein Proteins 0.000 description 3
- 101710083689 Probable capsid protein Proteins 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000901842 Escherichia coli W Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000001320 lysogenic effect Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101150010882 S gene Proteins 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002616 endonucleolytic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 239000007160 ty medium Substances 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57093062A JPS58212781A (ja) | 1982-06-02 | 1982-06-02 | 新種バクテリオフア−ジ及びその育種法 |
| US06/498,802 US4865979A (en) | 1982-06-02 | 1983-05-27 | Novel bacteriophage and method for breeding thereof |
| EP83303125A EP0095934B1 (en) | 1982-06-02 | 1983-06-01 | Novel bacteriophage and method for breeding thereof |
| DE8383303125T DE3381989D1 (de) | 1982-06-02 | 1983-06-01 | Bakteriophage und verfahren zur zuechtung. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57093062A JPS58212781A (ja) | 1982-06-02 | 1982-06-02 | 新種バクテリオフア−ジ及びその育種法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58212781A true JPS58212781A (ja) | 1983-12-10 |
| JPH0149479B2 JPH0149479B2 (enExample) | 1989-10-24 |
Family
ID=14072023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57093062A Granted JPS58212781A (ja) | 1982-06-02 | 1982-06-02 | 新種バクテリオフア−ジ及びその育種法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4865979A (enExample) |
| EP (1) | EP0095934B1 (enExample) |
| JP (1) | JPS58212781A (enExample) |
| DE (1) | DE3381989D1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61274683A (ja) * | 1985-05-29 | 1986-12-04 | Kikkoman Corp | ベクタ− |
| JPH03502886A (ja) * | 1988-02-26 | 1991-07-04 | バイオソース・ジェネティクス・コーポレイション | 非核染色体形質転換 |
| US6054305A (en) * | 1996-10-03 | 2000-04-25 | Kikkoman Corporation | Pyruvate orthophosphate dikinase gene, recombinant DNA, and process for producing pyruvate orthophosphate dikinase |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284492B1 (en) | 1988-02-26 | 2001-09-04 | Large Scale Biology Corporation | Recombinant animal viral nucleic acids |
| US6054566A (en) | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
| US5316931A (en) * | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
| US5427908A (en) * | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| CA2186962A1 (en) * | 1994-04-05 | 1995-10-12 | Richard M. Carlton | Antibacterial therapy with genotypically modified bacteriophage |
| US20010043924A1 (en) * | 1994-04-05 | 2001-11-22 | Exponential Biotherapies, Inc. | Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense system |
| US5741697A (en) * | 1995-11-30 | 1998-04-21 | University Of Rochester | Bacteriophage of chlamydia psittaci |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53133684A (en) * | 1977-04-26 | 1978-11-21 | Noda Sangyo Kagaku Kenkyusho | Novel bacteriophage and fabricating same |
| FR2422685A1 (fr) * | 1978-04-14 | 1979-11-09 | Pasteur Institut | Vecteurs, derives du bacteriophage lambda, permettant l'insertion et l'expression d'un gene, procaryote ou eucaryote, sous le controle du promoteur et de l'operateur de l'operon lactose de la bacterie escherichia coli |
| JPS5558096A (en) * | 1978-10-25 | 1980-04-30 | Noda Sangyo Kagaku Kenkyusho | Method of making novel recombined dna |
| JPS5561798A (en) * | 1978-10-30 | 1980-05-09 | Noda Sangyo Kagaku Kenkyusho | Preparation of novel recombination dna |
| JPS5835198A (ja) * | 1981-08-28 | 1983-03-01 | Mitsubishi Petrochem Co Ltd | 新規ベクター |
| JPS5869898A (ja) * | 1981-10-23 | 1983-04-26 | Noda Sangyo Kagaku Kenkyusho | 新規なテンペレ−トフア−ジｄｎａ |
-
1982
- 1982-06-02 JP JP57093062A patent/JPS58212781A/ja active Granted
-
1983
- 1983-05-27 US US06/498,802 patent/US4865979A/en not_active Expired - Lifetime
- 1983-06-01 DE DE8383303125T patent/DE3381989D1/de not_active Expired - Lifetime
- 1983-06-01 EP EP83303125A patent/EP0095934B1/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61274683A (ja) * | 1985-05-29 | 1986-12-04 | Kikkoman Corp | ベクタ− |
| JPH03502886A (ja) * | 1988-02-26 | 1991-07-04 | バイオソース・ジェネティクス・コーポレイション | 非核染色体形質転換 |
| US6054305A (en) * | 1996-10-03 | 2000-04-25 | Kikkoman Corporation | Pyruvate orthophosphate dikinase gene, recombinant DNA, and process for producing pyruvate orthophosphate dikinase |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0149479B2 (enExample) | 1989-10-24 |
| EP0095934A3 (en) | 1985-08-14 |
| EP0095934B1 (en) | 1990-11-14 |
| EP0095934A2 (en) | 1983-12-07 |
| DE3381989D1 (de) | 1990-12-20 |
| US4865979A (en) | 1989-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guan et al. | Bacteriophage genome engineering with CRISPR–Cas13a | |
| Harm et al. | Infection of transformable cells of Haemophilus influenzae by bacteriophage and bacteriophage DNA | |
| Yen et al. | Characterization of the gene transfer agent made by an overproducer mutant of Rhodopseudomonas capsulata | |
| JP3640958B2 (ja) | 効率的抑制遣伝子要素のための方法および用途 | |
| Lynch et al. | Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex | |
| US4348477A (en) | Method for preparing a recombinant DNA phage | |
| KR20160030187A (ko) | 간의 표적화 및 치료를 위한 ＣＲＩＳＰＲＣａｓ 시스템, 벡터 및 조성물의 전달 및 용도 | |
| KR20160056869A (ko) | 바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용 | |
| KR20160019553A (ko) | 유사분열 후 세포의 질병 및 장애를 표적화하고 모델링하기 위한 시스템, 방법 및 조성물의 전달, 유전자 조작 및 최적화 | |
| KR101725570B1 (ko) | 그람 음성균에 대해 세포 사멸능을 갖는 포도비리대 박테리오파지 | |
| US4348478A (en) | Method for preparation of a recombinant DNA phage | |
| Xiang et al. | Biological characteristics and whole-genome analysis of the Enterococcus faecalis phage PEf771 | |
| Reynolds et al. | Identification of the binding protein which may be the target of penicillin action in Bacillus megaterium | |
| JPS58212781A (ja) | 新種バクテリオフア−ジ及びその育種法 | |
| KR20240036522A (ko) | RNA-가이드 CasΩ 뉴클레아제 및 진단 및 요법에서의 이의 용도 | |
| Askora et al. | Lysogenic conversion of the phytopathogen Ralstonia solanacearum by the P2virus ϕRSY1 | |
| Ribeiro et al. | Characterization of a new podovirus infecting Paenibacillus larvae | |
| US4332897A (en) | Novel bacteriophage and method for preparing same | |
| CN108126190A (zh) | 分枝杆菌噬菌体裂解酶Lysin-Guo1的制备与应用 | |
| CN119060987B (zh) | 一种噬菌体解聚酶dep253在降解细菌荚膜多糖中的用途 | |
| CN116410969A (zh) | 一种噬菌体、噬菌体裂解酶及其用途 | |
| RU2112800C1 (ru) | Штамм пилеспецифического бактериофага pseudomonas aeruginosa гнцпм n 03, используемый для приготовления лечебного препарата против синегнойной палочки | |
| CN117965459B (zh) | 一种大肠杆菌噬菌体菌株04922C及其表达产物解聚酶Depo54和应用 | |
| Hallick et al. | Genetic and biochemical properties of an association complex between host components and lambda DNA | |
| Zamani et al. | Molecular investigation of two novel bacteriophages of a facultative methylotroph, Raoultella ornithinolytica: first report of Raoultella phages |